Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For YNDX
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.76 0.86 0.89
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -41.21 4.06 6.91
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 6.54 853.97 801.55
Cash -84.77 40.35 264.94
Capex inf 0.00 -103.19
Free Cash Flow inf 0.00 -69.92
Revenue -99.55 2.89 649.59
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -54.49 0.22 0.49
Operating Margin 61212.48 -7.16 0.01
ROA 95.75 0.02 < 0.005
ROE 91.20 0.04 -0.02
ROIC 72.89 -0.02 -0.09
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of YNDX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of YNDX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of YNDX is permitted for members.